Home > Health > Urolift Advanced Tissue Control to Treat Benign Prostatic Hyperplasia

Urolift Advanced Tissue Control to Treat Benign Prostatic Hyperplasia

62 Views

Urolift Advanced Tissue Control to Treat Benign Prostatic Hyperplasia 3

Teleflex has launched the Urolift Advanced Tissue Control system, a product designed to treat patients with benign prostatic hyperplasia (BPH). The system can be used to open the urethra by inserting small implants that hold the lobes of the prostrate in a retracted position. The device is specifically tailored to treat those with challenging prostatic anatomy, including those with large lateral lobes and an obstructive median lobe.

BPH is a common condition affecting perhaps over 500 million men globally, and it often occurs with increasing age. For men who are affected, it can lead to a decreased quality of life. Treatments include medication or surgical intervention, but these approaches don’t always work well for everyone.

Urolift Advanced Tissue Control to Treat Benign Prostatic Hyperplasia 5

The Urolift system aims to provide a minimally invasive approach to treating the condition, and does not require an incision or destructive enlargement of the urethra. Patients can be treated in an outpatient procedure that takes only about an hour or two. A urologist can advance the device into the urethra under cystoscopic visualization, and then use it to insert small implants around the enlarged prostatic lobes, pushing them aside to create more space.

Tissue control wings that help to hold tissue back during the procedure are included in the new system, helping the urologist to visualize the blockage more easily. The device tip has also been enhanced, making it easier to deliver the implants. Laser-etched indicators on the needle location marker also help to predictably place the implants.

“We are encouraged by early positive responses from urologists to the UroLift ATC System,” said Dave Amerson, president of the Teleflex Interventional Urology business unit, in an announcement. “Urologists are reporting high satisfaction with its ease of use and indicating their willingness to adopt the new device in their practices to treat patients with challenging anatomies, including obstructive median lobe and large lateral lobes.”

Here’s a link to a video about the Urolift system…

Product page: Urolift

Via: Teleflex




Urolift Advanced Tissue Control to Treat Benign Prostatic Hyperplasia 7

Conn Hastings

Conn Hastings received a PhD from the Royal College of Surgeons in Ireland for his work in drug delivery, investigating the potential of injectable hydrogels to deliver cells, drugs and nanoparticles in the treatment of cancer and cardiovascular diseases. After achieving his PhD and completing a year of postdoctoral research, Conn pursued a career in academic publishing, before becoming a full-time science writer and editor, combining his experience within the biomedical sciences with his passion for written communication.




Source link

TAGS
Hi guys, this is Kimmy, I started LicensetoBlog to help you with the latest updated news about the world with daily updates from all leading news sources. Beside, I love to write about several niches like health, business, finance, travel, automation, parenting and about other useful topics to keep you find the the original information on any particular topic. Hope you will find LicensetoBlog helpful in various ways. Keep blogging and help us grow as a community for internet lovers.